Tissue Regenix Group (LON:TRX) Shares Down 2.8%

Tissue Regenix Group plc (LON:TRX)’s share price was down 2.8% during trading on Wednesday . The company traded as low as GBX 59.80 ($0.74) and last traded at GBX 59.80 ($0.74). Approximately 44,239 shares traded hands during mid-day trading, a decline of 33% from the average daily volume of 65,903 shares. The stock had previously closed at GBX 61.50 ($0.77).

Tissue Regenix Group Trading Down 2.8 %

The business has a 50-day simple moving average of GBX 64.54 and a two-hundred day simple moving average of GBX 58.26. The stock has a market cap of £42.20 million, a price-to-earnings ratio of -2,990.00 and a beta of 1.48. The company has a debt-to-equity ratio of 32.01, a current ratio of 4.03 and a quick ratio of 2.36.

Tissue Regenix Group Company Profile

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.